A Recombinant Protein COVID-19 Vaccine

· Sinocelltech Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A Recombinant Protein COVID-19 Vaccine, covering 2023-07-06 to 2023-07-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines [Phase 2]

See pricing